Overall, our study elucidates the molecular mechanism through which PDSS2-Del2 promotes HCC metastasis, potentially contributing to the development of effective clinical treatments for HCC and preventing tumor metastasis. Here, PDSS2 is linked to hepatocellular carcinoma.